Christopher Cramer

Mr. Cramer leads business development at CytoSorbents and has more than 15 years of business development and commercial experience in the medical device field. Most recently, he was Senior Director of New Venture Development at Johnson & Johnson (J&J). He helped to create and manage J&J’s portfolio of early-stage ventures from inception to product launch, establishing new revenue streams for Johnson & Johnson. He was personally responsible for initiating and driving significant partnership deal flow and has substantial experience in negotiating and establishing business development relationships across many commercial, non-profit, and government organizations. These deals encompassed a wide variety of structures, including distribution, promotion, co-development, licensing, merger and acquisitions, and equity investments. Prior to that, he was the Worldwide Strategic Marketing leader responsible for developing and executing branding and business development strategies for J&J’s minimally invasive weight-loss surgery division. Prior to J&J, he held multiple leadership positions at PwC Consulting and Parametric Technology Corporation. Chris earned his BS degree from Miami University and MBA and MS degrees from Carnegie Mellon University.